Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rocket Pharmaceuticals (RCKT) Gross Profit: 2016-2025

Historic Gross Profit for Rocket Pharmaceuticals (RCKT) over the last 9 years, with Sep 2025 value amounting to -$473,000.

  • Rocket Pharmaceuticals' Gross Profit fell 0.42% to -$473,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.9 million, marking a year-over-year decrease of 0.42%. This contributed to the annual value of -$1.9 million for FY2024, which is 0.59% down from last year.
  • Rocket Pharmaceuticals' Gross Profit amounted to -$473,000 in Q3 2025, which was down 0.00% from -$473,000 recorded in Q2 2025.
  • In the past 5 years, Rocket Pharmaceuticals' Gross Profit ranged from a high of -$251,000 in Q2 2021 and a low of -$1.7 million during Q1 2021.
  • Over the past 3 years, Rocket Pharmaceuticals' median Gross Profit value was -$471,000 (recorded in 2024), while the average stood at -$470,818.
  • Per our database at Business Quant, Rocket Pharmaceuticals' Gross Profit spiked by 85.95% in 2021 and then tumbled by 85.26% in 2022.
  • Rocket Pharmaceuticals' Gross Profit (Quarterly) stood at -$463,000 in 2021, then fell by 0.86% to -$467,000 in 2022, then declined by 0.64% to -$470,000 in 2023, then declined by 0.64% to -$473,000 in 2024, then declined by 0.42% to -$473,000 in 2025.
  • Its Gross Profit stands at -$473,000 for Q3 2025, versus -$473,000 for Q2 2025 and -$472,000 for Q1 2025.